D. E. Shaw & Co., Inc. - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 178 filers reported holding AXSOME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.4%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,418,194
-2.7%
34,6000.0%0.00%0.0%
Q2 2023$2,486,356
+31.7%
34,600
+13.1%
0.00%
+50.0%
Q1 2023$1,887,408
+144.7%
30,600
+206.0%
0.00%
+100.0%
Q4 2022$771,300
+197.8%
10,000
+47.9%
0.00%
Q2 2022$259,000
-96.0%
6,762
-95.6%
0.00%
-100.0%
Q1 2022$6,432,000
+89.2%
155,392
+72.7%
0.01%
+100.0%
Q4 2021$3,400,000
+134.8%
90,000
+104.8%
0.00%
+200.0%
Q3 2021$1,448,000
-70.9%
43,939
-40.5%
0.00%
-75.0%
Q2 2021$4,982,000
+4.7%
73,849
-12.1%
0.00%
-20.0%
Q1 2021$4,757,000
-73.2%
84,018
-61.5%
0.01%
-68.8%
Q4 2020$17,759,000
-11.6%
217,982
-22.7%
0.02%
-23.8%
Q3 2020$20,096,000
-20.3%
282,042
-8.0%
0.02%
-30.0%
Q2 2020$25,219,000
+2.2%
306,503
-26.9%
0.03%
-23.1%
Q1 2020$24,679,000
+155.4%
419,495
+348.8%
0.04%
+254.5%
Q4 2019$9,661,000
+297.9%
93,463
-22.1%
0.01%
+266.7%
Q3 2019$2,428,000
+171.3%
119,951
+245.1%
0.00%
+200.0%
Q2 2019$895,00034,7560.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,008,508$82,980,00048.53%
Fairmount Funds Management LLC 216,098$17,781,0007.93%
WMS Partners, LLC 250,000$20,570,0004.26%
RTW INVESTMENTS, LP 1,658,316$136,446,0003.84%
MORGAN JESS S & CO INC 39,328$3,236,0003.51%
RA Capital Management 2,035,132$167,451,0003.26%
Ghost Tree Capital, LLC 100,000$8,228,0002.17%
ACUTA CAPITAL PARTNERS, LLC 90,000$7,405,0002.14%
Avidity Partners Management LP 404,900$33,315,0002.14%
IRIDIAN ASSET MANAGEMENT LLC/CT 1,085,836$89,343,0001.97%
View complete list of AXSOME THERAPEUTICS INC shareholders